PROM1 and medulloblastoma: To confirm the effects of NRP1 inhibition with MR438 on medulloblastoma stem cells, we evaluated the expression of stem cell markers (CD15, CD133 and Sox2) as well as the self-renewal ability of medulloblastoma cells to form medullospheres after tumor dissociation (Fig. 4).